(Medical Xpress) -- A probiotic treatment appears to mitigate pancreatitis in an animal model, leading to a new hypothesis of how probiotics may act, according to a paper in the November Applied and Environmental Microbiology. ...
Nov 17, 2011
0
0
(Medical Xpress)—Rats and humans have at least one thing in common: They both react the same way to a placebo, according to a new University of Florida study.
Nov 28, 2012
0
0
Are you good at coping when life gets tough? Do people call you a straight-shooter? Will you help others without expecting anything in return?
Nov 15, 2012
0
0
A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine ...
Jul 1, 2013
0
3
The EU's medicines watchdog could start a review within days of an oral COVID drug produced by the US pharmaceutical firm Merck, a senior official said Tuesday.
Oct 5, 2021
0
13
Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbVie.
Jun 20, 2022
0
4
(HealthDay)—For patients with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin disease characterized by painful abscesses, nodules, and draining fistulas in the axilla and groin, treatment with once-weekly ...
Dec 18, 2012
0
0
Placebos have helped to ease symptoms of illness for centuries and have been a fundamental component of clinical research to test new drug therapies for more than 70 years. But why some people respond to placebos and others ...
Apr 13, 2015
0
27
The results of a study conducted at MedUni Vienna under the direction of Michaela Bayerle-Eder, doctor of internal and sexual medicine, showed that the sexual response of men, whose female partners had been treated with the ...
May 18, 2017
0
0
They found that it is possible to turn a neuron which previously hasn't responded to placebos (placebo 'non-responder' neuron) into a placebo 'responder' by conditioning Parkinson patients with apomorphine, a dopaminergic ...
Feb 9, 2016
0
100
